August 1, 2022
Marking its 20th global recipient, the grant program supports next-generation sequencing-based research to explore new and expanded applications for molecular testing CARLSBAD, Calif. - As part of its continued commitment to expand the benefits of next-generation sequencing (NGS), Thermo Fisher Scientific is now accepting submissions for the fifth round of the Oncomine Clinical Research Grant program. [...]
August 1, 2022
DECTRIS is proud to introduce its latest development: DECTRIS ARINA, a new hybrid-pixel electron detector designed for 4D STEM applications. This detector model was first presented to the community at the M&M 2022 in Portland and will be available for ordering in summer 2023. In the meantime, DECTRIS will continue its collaboration with industrial and academic [...]
New Cryo-Plasma Focused Ion Beam to Streamline Cellular Cryo-Electron Tomography Research
August 1, 2022
Thermo Scientific Arctis Cryo-Plasma FIB enables speed and consistency of cellular cryo-electron tomography HILLSBORO, Ore. - Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Thermo Scientific Arctis Cryo-Plasma Focused Ion Beam (Cryo-PFIB), a new connected and automated microscope designed to advance the pace of cryo-electron tomography (cryo-ET) research. Cryo-ET makes [...]
Covaris Appoints Annemarie Watson as Chief Executive Officer
August 1, 2022
WOBURN, Mass. -- Covaris, LLC (“Covaris” or “the Company”), a manufacturer of advanced tools enabling life science innovations, announced today that it has appointed Annemarie Watson as Chief Executive Officer, effective immediately. Ms. Watson succeeds Covaris founder Jim Laugharn, who will remain an investor in Covaris and on serve on the Company’s Board of Directors, [...]
Eppendorf opens new site in Singapore
August 1, 2022
New subsidiary at the center of the Asian life science growth markets Targeted strengthening of customer focus with high-tech laboratory for pipette calibration and extensive range of high-quality laboratory services Even faster and more reliable delivery thanks to new central warehouse Singapore/Hamburg - The globally active Eppendorf Group continues its growth track in Asia in [...]
August 1, 2022
COVID-19 Consortium and resulting Science paper validated the Carterra platform as a game-changer in antibody discovery (Salt Lake City, Utah and La Jolla, California) – Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, and La Jolla Institute for Immunology (LJI), a globally recognized non-profit research organization dedicated to understanding the power of the [...]
Tosoh to Increase Production Capacity of Separation and Purification Media
August 1, 2022
Tokyo, Japan—Tosoh Corporation has announced it will increase the production capacity of separation and purification media TOYOPEARL® and TSKgel® PW at its Nanyo Complex (Shunan City, Yamaguchi Prefecture) in response to the growing demand for antibody and oligonucleotide drug purification. Separation and purification media are key products of Tosoh’s Bioscience Division and are used in the purification [...]
August 1, 2022
NORWOOD, Mass. -- Advanced Instruments, a leading manufacturer of analytical instruments and services for bioprocessing, today announced the acquisition of SAL Scientific Ltd., a private company that develops and manufactures a portfolio of cell growth supplements for Chinese Hamster Ovary (CHO) and Human Embryonic Kidney (HEK) cells. These reagents substantially improve cell growth under stressful conditions [...]
August 1, 2022
Carlsbad CA and Research Triangle Park NC -- CUT&Tag is a targeted transposition technique that allows high-resolution genomic mapping of histone modifications and chromatin- associated proteins through the precise insertion of DNA sequences into the genome using the Tn5 transposase enzyme. EpiCypher and Active Motif each own or control patents covering complementary aspects of targeted [...]
Active Motif Incorporated Licenses Targeted Transposition Technology to Diagenode S.A.
August 1, 2022
Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precision medicine, announced that it has non-exclusively licensed its foundational patents in transposition for use in CUT&Tag epigenetic assays to Diagenode S.A., a Hologic company (NASDAQ:HOLX). The innovations underlying these patents allow mechanistic, translational, and clinical researchers to interrogate open chromatin [...]

